Adjacent Segment Disease Clinical Trial
Official title:
Decompression Versus Decompression and Fusion for Lumbar Adjacent Segment Disease
Adjacent segment disease (ASD) in the lumbar spine is a well-known sequela of lumbar fusion surgery. The annual incidence of adjacent level re-operation is approximately 3% with a ten-year prevalence of 20-30%. Frequently, the surgical treatment involves decompression of the adjacent level coupled with extension of the instrumentation and fusion. Advocates of this paradigm cite the altered kinematics and biomechanics of levels adjacent to a lumbar fusion mass. Furthermore, decompressed levels adjacent to a fused segments are associated with higher rates of ASD in retrospective studies. Yet, a retrospective review of higher quality data concluded decompression adjacent to single-level fusion provides similar outcomes compared to fusions extending across the decompressed segments. Given the conflicting data currently available, higher quality data are needed to guide surgical decision-making in ASD. The purpose of this trial is to prospectively compare decompression and decompression with fusion in patients with lumbar ASD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04320043 -
Adjacent Segment Disease After Anterior Cervical Decompression Surgery
|
||
| Not yet recruiting |
NCT04970862 -
Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration
|